Liminatus Pharma, LLC (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
8.04
-2.03 (-20.16%)
May 2, 2025, 4:00 PM EDT - Market closed
Liminatus Pharma, LLC Market Cap
Liminatus Pharma, LLC has a market cap or net worth of $56.88 million as of May 2, 2025. Its market cap has decreased by -79.91% in one year.
Market Cap
56.88M
Enterprise Value
n/a
1-Year Change
-79.91%
Ranking
Category
Stock Price
$8.04
Market Cap Chart
Since May 26, 2021, Liminatus Pharma, LLC's market cap has decreased from $276.83M to $56.88M, a decrease of -79.45%. That is a compound annual growth rate of -33.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 56.88M | -28.99% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -72.98% |
| Dec 30, 2022 | 279.31M | 3.48% |
| Dec 31, 2021 | 269.93M | -2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.29B |
| Johnson & Johnson | 371.71B |
| UnitedHealth Group | 367.55B |
| AbbVie | 344.46B |
| Novo Nordisk | 293.18B |
| Abbott Laboratories | 228.61B |
| Novartis AG | 223.05B |
| AstraZeneca | 221.80B |